According to the current analysis of Reports and Data, the
global Amoxicillin
Market was valued at USD 4,408.1 million in 2018 and is expected to
reach USD 4,962.6 million by the year 2026, at a CAGR of 1.5%. The amoxicillin
antibiotics is a generic category of drug. It is also known by the name Amoxil
and is usually administered in the treatment involving bacterial infections.
The compound belongs to the β-lactam drug class of antibiotics. The amoxicillin
medication is used in treating infections such as, pneumonia, ear infections,
bronchitis, sinusitis, infections of the skin, and urinary tract infection
(UTI). Its use for UTI is found to be used most than any other antibiotics.
This antibiotic can also be taken in combinations with other drugs, such as
amoxicillin and clavulanate potassium, it is used for treating bacterial
infections mentioned before. The use of amoxicillin antibiotics for tooth
infection is also popular. The increasing frequencies of bacterial infections
in low-income countries, developing countries and other parts of the world will
be the most significant factor in driving the growth of this market. Also the
increasing research and applications of combination drugs with this medication
will fasten the progress of the market. Furthermore, these medicines are safe
to be taken together with birth control pills. Although, the possible side
effects of amoxicillin are expected to hamper the development of the market to
some extent.
The market is segmented on the basis of the diseases, the
route administration, drug formulation, and distribution channels involved in
distributing the medicine. The medication is available in tablet, capsule,
suspension, syrup, and powder form, through hospital pharmacies, drug stores,
retail stores and online pharmacies. It can be taken orally and through
intravenous route as well. Some specific combinational medications are also
prescribed for pregnant women. It includes, erythromycin or clarithromycin in
combination with amoxicillin if the patient is pregnant with moderately severe
infection; and Co-amoxiclav with clarithromycin, or erythromycin if the patient
is pregnant with high-severity infection.
Furthermore, increased government initiatives for
encouraging the use of this medicine, availability of research funds from
private as well as public bodies, improvement in the reimbursement scenario,
and rising awareness about multiple benefits of amoxicillin prescription are
among the key factors propelling the growth of the market. Other medication
alternatives of antibiotic amoxicillin are anticipated to impede the market
growth. However according to a recent update from Journal of the American
College of Cardiology it was found that Cipro or Ciprofloxacin, owns huge risk
of escalating a heart-valve problem than another broad-spectrum antibiotic
specifically amoxicillin.
To identify the key trends in the industry, click on the
link below:
Further key findings from the report suggest
- The
online pharmacies segment is expected to grow with a CAGR of 1.9% during
the forecast period. Retail pharmacies i.e. drug stores remains the chief
revenue generating segment in global market for the target antibiotic
drug.
- Antibiotics
are used to save thousands of lives each year by killing the harmful
bacteria in the body. However these antibiotics destroys the desired
bacteria in the human intestines, known as the microbiome, as well, which
can result into potential health problems. Doctors are aware now that each
antibiotic prescription has the potential to lead to some very harmful
microbiome-related health outcomes in the patient. These dynamics hold the
potential to disrupt the market of amoxicillin.
- A study
on effectiveness of antibiotics on treating non severe acute exacerbations
in children with non-cystic fibrosis bronchiectasis recently claimed that
amoxicillin should remain the first line antibiotic for treating the same.
The study took three antibiotics under consideration in the study,
placebo, azithromycin plus placebo amoxicillin clavunate.
- There
is an assortment of branded and generic rendition of amoxicillin
medications are accessible in the market. Many manufacturers are
manufacturing amoxicillin sedates and conveying in the market. The
amoxicillin medications can likewise utilize a blend with different
medications used to treat a bacterial disease, for example, triple
treatment (amoxicillin/clarithromycin/lansoprazole) and double treatment (amoxicillin/lansoprazole).
These double and triple treatments are under clinical preliminaries.
- North
America remains the key revenue generating geographical segment in
Amoxicillin market. The geographical segment accounted for USD 1.42
billion in 2018. Availability of research funds from public as well as
private sources, availability of state-of-art technologies, presence of
key market players in the region, favorable reimbursements scenarios,
rising focus on precision medicine, and rising awareness about treatments
of infectious diseases, are among the key factors driving the market
growth for Amoxicillin in this region.
- The
global Amoxicillin market is highly fragmented with major players like
JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun
Pharmaceuticals, Proficient Rx LP., Sanis Health Inc, Nucare
Pharmaceuticals, Inc., Northwind Pharmaceuticals, A-S Medication
Solutions, Bryant ranch prepack and others., collectively constituting a
competitive market
Request For FREE
Sample PDF Copy of This Research Report at: https://www.reportsanddata.com/sample-enquiry-form/2151
For the purpose of this report, Reports and Data has
segmented the Amoxicillin market on the basis of infection type, form of drug,
route, distribution channel and region:
Infection Type Outlook (Revenue in Million USD;
2016–2026)
- Skin
Infections
- ENT
(Ear, Nose & Throat) Infections
- Stomach
Infections
- Lungs
Infections
- Urinary
tract infections (UTI)
- Pneumonia
- Bronchitis
- Gonorrhea
Route of Administration Outlook (Revenue in Million USD;
2016–2026)
- Oral
- Intravenous
Form Outlook (Revenue in Million USD; 2016–2026)
- Tablets
- Capsule
- Suspensions
- Syrup
- Powder
Distribution Channels Outlook (Revenue in Million USD;
2016–2026)
- Hospitals
Pharmacies
- Retail
Pharmacies
- Online
Pharmacies
- Others
Regional Outlook (Revenue in Million USD; 2016–2026)
- North
America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest
of the Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia-Pacific
- Middle
East & Africa
- Latin
America
Make an Inquiry at: https://www.reportsanddata.com/make-enquiry-form/2151
No comments:
Post a Comment